June 20, 2008
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organization (BIO)
June 2, 2008
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People with Multiple Sclerosis
privacy policy
|
terms of use
| Copyright© 2004-2006 Acorda Therapeutics Inc. All rights reserved
